Literature DB >> 15135717

Validation of the i-STAT handheld activated clotting time for use with bivalirudin.

Jeffrey M Schussler1, Stuart R Lander, Laurie A Wissinger, Azam Anwar, Michael S Donsky, Kenneth B Johnson, Ravi C Vallabhan, Jason B Wischmeyer.   

Abstract

Bivalirudin is being used more frequently as an anticoagulant in the cardiac catheterization laboratory. Newer devices, used to measure activated clotting time (ACT), have not been thoroughly tested for use with bivalirudin. One such device, the i-STAT ACT, measures the generation of activated thrombin to determine the level of anticoagulation. Our study demonstrated a high level of agreement between the i-STAT ACT and the Hemochron ACT in patients anticoagulated with bivalirudin. In addition, the i-STAT was shown to have an extremely high degree of reproducibility.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15135717     DOI: 10.1016/j.amjcard.2004.01.076

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  1 in total

1.  Clinical Evaluation of Measuring the ACT during Elective Cardiac Surgery with Two Different Devices.

Authors:  Florian Falter; Nabeel Razzaq; Martin John; Jens Fassl; Markus Maurer; Sean Ewing; Ross Hofmeyr
Journal:  J Extra Corpor Technol       Date:  2018-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.